...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: HIV

 jonzobot,,,,,,what ever this means ,,,,***are encouraged to contact Resverlogix to further the research and development of apabetalone as a therapeutic for HIV-1 eradication,” stated Donald McCaffrey****.

I dont think we expect to continue on the research path but the opportunity to the field of experts are being given a freebie most likely!!,,and good for all humanity if the case,,,kudos to the management team!!

RVX news release excerpt;

“Apabetalone’s unique epigenetic mechanism of action has once again been tied to another important grievous disease for which there is no cure. In order to help expedite development in this space, interested HIV/AIDS stakeholders such as patient advocacy groups, government health bodies, major phamaceutical companies, and/or non-government research organization (NRO’s) are encouraged to contact Resverlogix to further the research and development of apabetalone as a therapeutic for HIV-1 eradication,” stated Donald McCaffrey, President & CEO of Resverlogix.

https://www.resverlogix.com/investors/news?article=610

 

Share
New Message
Please login to post a reply